FDA commissioner Rob Califf (Graeme Sloan/Sipa USA)(Sipa via AP Images)

Up­dat­ed: FDA push­es to make opi­oid over­dose re­ver­sal agents OTC prod­ucts as com­pa­nies balk

Mem­bers of Con­gress on both sides of the aisle have slammed the FDA for fail­ing to take ad­e­quate ac­tion to help the sky­rock­et­ing death toll from opi­oid over­dos­es.

Tak­ing that cri­tique to heart, the FDA said Tues­day that it is mov­ing for­ward with a pre­vi­ous­ly hatched plan to make cer­tain opi­oid over­dose re­ver­sal agents (i.e. nalox­one nasal sprays and au­toin­jec­tors) over-the-counter prod­ucts, po­ten­tial­ly in­creas­ing their avail­abil­i­ty.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.